title: Early-life infection is a vulnerability factor for aging-related glial alterations and cognitive decline.
abstract: There is significant individual variability in cognitive decline during aging, suggesting the existence of "vulnerability factors" for eventual deficits. Neuroinflammation may be one such factor; increased glial reactivity is a common outcome of aging, which in turn is associated with numerous neurodegenerative conditions. Early-life infection leads to cognitive impairment in conjunction with an inflammatory challenge in young adulthood, which led us to explore whether it might also accelerate the cognitive decline associated with aging. Rats were treated on postnatal day 4 with PBS or Escherichia coli, and then tested for learning and memory at 2 or 16months of age, using two fear-conditioning tasks (context pre-exposure and ambiguous cue), and a spatial water maze task. Neonatally-infected rats exhibited memory impairments in both the ambiguous cue fear-conditioning task and in the water maze, but only at 16months. There were no differences in anxiety between groups. Neonatally-infected rats also exhibited greater aging-induced increases in glial markers (CD11b and MHCII on microglia, and GFAP on astrocytes), as well as selective changes in NMDA receptor subunit expression within the hippocampus, but not in amygdala or parietal cortex compared to controls. Taken together, these data suggest that early-life infection leads to less successful cognitive aging, which may be linked to changes in glial reactivity.
authors.affiliation: Duke University, Department of Psychology & Neuroscience, Durham, NC 27708, USA. staci.bilbo@duke.edu <staci.bilbo@duke.edu>
authors.forename: Staci D
authors.initials: SD
authors.lastname: Bilbo
mesh_terms: D000375:Aging; D000818:Animals; D000831:Animals, Newborn; D001007:Anxiety; D001921:Brain / Q000378:metabolism*; D003072:Cognition Disorders / Q000378:metabolism / Q000503:physiopathology*; D003214:Conditioning, Classical; D004927:Escherichia coli Infections; D005239:Fear / Q000502:physiology; D007239:Infections; D008297:Male; D018782:Maze Learning / Q000502:physiology; D008568:Memory / Q000502:physiology; D008569:Memory Disorders / Q000378:metabolism / Q000503:physiopathology; D009457:Neuroglia / Q000378:metabolism*; D009483:Neuropsychological Tests; D051381:Rats; D016194:Receptors, N-Methyl-D-Aspartate / Q000378:metabolism; D013997:Time Factors
chemical_list: D016194:Receptors, N-Methyl-D-Aspartate
references.citation: J Neurosci. 2008 Sep 3;28(36):8945-54
references.pmid: 18768688
references.citation: Eur J Neurosci. 2008 Feb;27(3):644-53
references.pmid: 18279317
references.citation: J Physiol. 2007 Jun 15;581(Pt 3):1057-81
references.pmid: 17412766
references.citation: Brain Behav Immun. 1995 Jun;9(2):113-28
references.pmid: 7549035
references.citation: Psychol Bull. 1992 Nov;112(3):433-45
references.pmid: 1438637
references.citation: Prog Neurobiol. 2003 Feb;69(3):143-79
references.pmid: 12758108
references.citation: Behav Brain Res. 2002 Aug 21;134(1-2):291-8
references.pmid: 12191816
references.citation: Methods. 2001 Dec;25(4):402-8
references.pmid: 11846609
references.citation: J Neurosci. 2000 Mar 1;20(5):1666-74
references.pmid: 10684868
references.citation: Front Behav Neurosci. 2009 Aug 24;3:14
references.pmid: 19738918
references.citation: Anal Biochem. 1987 Apr;162(1):156-9
references.pmid: 2440339
references.citation: Neurobiol Aging. 2006 May;27(5):717-22
references.pmid: 15890435
references.citation: J Neurosci. 2004 Mar 10;24(10):2431-9
references.pmid: 15014118
references.citation: Brain Behav Immun. 2008 May;22(4):451-5
references.pmid: 17997277
references.citation: J Neurosci. 2004 Sep 1;24(35):7648-53
references.pmid: 15342731
references.citation: Learn Mem. 2007 Mar 08;14(3):200-3
references.pmid: 17351145
references.citation: Nat Neurosci. 1999 Sep;2(9):833-9
references.pmid: 10461223
references.citation: J Neurosci. 2005 Aug 31;25(35):8000-9
references.pmid: 16135757
references.citation: J Biol Chem. 2000 Aug 25;275(34):26252-8
references.pmid: 10856294
references.citation: J Endocrinol. 2010 Jan;204(1):31-6
references.pmid: 19815586
references.citation: Brain Behav Immun. 2007 Mar;21(3):332-42
references.pmid: 17126527
references.citation: Behav Brain Res. 2006 Apr 25;169(1):39-47
references.pmid: 16413067
references.citation: Nat Neurosci. 2002 Feb;5(2):162-8
references.pmid: 11780144
references.citation: Brain Behav Immun. 2010 Mar;24(3):329-38
references.pmid: 19782746
references.citation: Brain Res Mol Brain Res. 2002 Feb 28;99(1):40-5
references.pmid: 11869807
references.citation: Science. 2007 Jul 6;317(5834):94-9
references.pmid: 17556551
references.citation: Exp Gerontol. 2010 May;45(5):351-6
references.pmid: 20138979
references.citation: Behav Neurosci. 2005 Feb;119(1):293-301
references.pmid: 15727533
references.citation: Neurosci Biobehav Rev. 2004 Nov;28(7):675-85
references.pmid: 15555677
references.citation: Front Aging Neurosci. 2010 Jan 04;1:6
references.pmid: 20552057
references.citation: Nucleic Acids Res. 2001 May 1;29(9):e45
references.pmid: 11328886
references.citation: Nat Neurosci. 2005 Dec;8(12):1657-9
references.pmid: 16286930
references.citation: Nat Neurosci. 2007 Jul;10(7):896-902
references.pmid: 17558402